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APACHE = Acute Physiology and Chronic Health Evaluation; APC = activated protein C; ARF = acute respiratory failure; BiPAP = bilevel positive
airway pressure; CPAP = continuous positive airway pressure; CT = computed tomography; FiO2 = fractional inspired oxygen; ICU = intensive care
unit; NIV = noninvasive ventilation; PaO2 = arterial oxygen tension.
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Cervical spine injury
Clearance of potential cervical spine (C-spine) injury in the
awake and cooperative patient with no distracting injury is a
standardized procedure. The process becomes more
problematic in the unconscious patient, leading to delay in
C-spine collar removal and consequent complications such as
tissue necrosis, raised intracranial pressure, excessive sedation
and so on. Two recent reports addressed this issue [1,2].
In the first of these [1] a postal questionnaire was sent to 32
neurosurgery and spinal injury departments in the UK, with
the aim of determining how they assessed the C-spine in
unconscious, adult trauma patients, and at what point
immobilization was discontinued. The response rate was
84% (n = 27).
The results demonstrated little consistency between units.
The majority of the units questioned had no formal protocol for
either screening investigations or criteria for discontinuation of
C-spine immobilization. All patients underwent at least one
plain C-spine X-ray. Out of 27 units, 12 used two X-ray views
alone, and only 10 out of 27 units routinely used computed
tomography (CT) scanning. One unit used magnetic
resonance imaging routinely and two used dynamic
fluoroscopy. Following negative imaging of one variety or
other, 12 units discontinued immobilization immediately, 10
continued until they were able to clear spines clinically, and
the remaining five were prepared to discontinue if the
patient’s condition required it. Over half of the patients had
immobilization discontinued on the basis of plain X-rays alone,
despite evidence that plain X-rays have poor diagnostic
sensitivity for C-spine fractures [3–5] and are inferior to CT.
The results suggest that there is often suboptimal and
inconsistent investigation, with a subsequent lack of rationale
for discontinuation of immobilization. It is suggested that
head injured patients receiving a CT scan of the brain should
routinely undergo C-spine CT scanning at the same time, and
that magnetic resonance imaging and dynamic fluoroscopy
are not necessary in these patients.
The second article [2], also employing a postal questionnaire
(95% response), looked at the major differences between
clinicians of differing specialities in the management of potential
C-spine injuries in unconscious adult patients. The specialities
included were intensivists, neurosurgeons, and orthopaedic and
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spinal surgeons. The report also reviews the available literature
and goes on to suggest a management protocol.
Consistent with the findings of Jones and coworkers [1],
Morris and Mullan [2] demonstrated great variations in
practice, attitudes and perceptions with regard to
management and evaluation of the potentially injured C-spine
in the unconscious patient. No consensus existed as to the
minimum standard of investigations required to clear the
C-spine in these circumstances. Recognition of the
complications of prolonged C-spine immobilization in the
critically ill patient was also patchy, with some clinicians
suggesting that immobilization should be indefinite until
clinical examination could be carried out in the awake patient.
Based upon a literature review and available consensus, the
working group devised a protocol for the investigation and
subsequent clearing, or not, of the C-spine in an unconscious
patient. Essentially, the protocol requires three-view X-rays of
the C-spine, an anteroposterior and a lateral thoracolumbar
X-ray, and a high-resolution CT of the craniocervical junction.
Exclusion of the injury should be within 48–72 hours.
This must be a step in the right direction, providing an
evidence-based approach to an all too common dilemma in
the intensive care unit (ICU).
Prone ventilation
A randomized controlled trial, recently reported in JAMA [6],
aimed to resolve the tricky issue of whether prone positioning
for acute hypoxaemic respiratory failure improves patient
survival. The trial involved 21 ICUs with a total of 791 patients
being assigned to one of two groups: continually supine or
intermittently prone. Randomization occurred between
12–24 hours following ICU admission. Twenty-eight day
mortality was the primary outcome measure. Patients were
eligible if they were intubated (or tracheostomized) with an
arterial oxygen tension (PaO2)/fractional inspired oxygen (FiO2)
ratio <300 mmHg and had an expected duration of ventilation
in excess of 48 hours. Patients were excluded if they were at
risk for harm from the prone positioning (e.g. raised intracranial
pressure) or had recently been ventilated in the prone position.
Patients in the supine group were managed entirely in that
position with a 30° head up tilt. Patients assigned to the
prone group were placed in a complete prone position for at
least 8 hours per day. However, if a patient developed severe
hypoxia in the supine position, then they could crossover to
the prone group. If a major complication attributable to prone
position occurred, then the patient was reverted to the
supine position.
Sadly 28-day mortality rates were not significantly different
between the two groups (31.5% for supine versus 32.4% for
prone). Ninety day mortality was also similar (42.2% for
supine versus 43.3% for prone). The duration of mechanical
ventilation and rates of successful extubation did not differ
significantly. However, ventilator associated pneumonia was
found to be significantly reduced in the prone group. Serious
side effects of positioning were significantly more frequent in
the prone group. These included accidental extubation, tube
obstruction and incidence of pressure sores.
The authors acknowledged several limitations in their trial,
including significant treatment group crossover and a failure
rate in excess of 25% in the prone positioning protocol.
However, the trial failed to show a reduction in mortality after
early prone positioning for acute hypoxaemic failure, despite
an improvement in oxygenation and a reduction in ventilator
associated pneumonia; also, it did demonstrate an increased
incidence of serious side effects from ventilation in the prone
position.
This report echoes the findings of Gattinoni and coworkers
[7] and begs the question, is there any evidence to justify
prone ventilation?
PROWESS
The November issue of Critical Care Medicine included
reports on two retrospective studies [8,9] based on the
PROWESS (Recombinant Human Activated Protein C
Worldwide Evaluation in Severe Sepsis) study [10] data
base, and discussed new post-28-day data.
In the first of these reports [8], outcome beyond 28 days and
health care resource utilization, employing the simplified
Therapeutic Intervention Scoring System, were examined.
Previous investigators have concluded that the cost-
effectiveness of activated protein C (APC) in the
management of severe sepsis compares favourably with that
of other health care interventions, despite its high up-front
cost. However, these findings were largely based on 28-day
data, and as such they do not take the entire hospital stay
into account. Laterre and coworkers point out that, at
28 days, more than 40% of the PROWESS survivors were
still in hospital and little is known of their health care
consumption from there on. Subgroup analysis, based on
previously defined groups, was also carried out.
Conclusions from that analysis are generally encouraging.
Survival from severe sepsis is significantly better at hospital
discharge for those treated with APC than for those not
treated with APC, and this remained the case for the majority
of subgroups. Furthermore, this increase in survival was not
associated with an increase in resource consumption, as
measured using the Therapeutic Intervention Scoring
System, or in terms of ICU and hospital length of stay. In
addition, a greater number of survivors in the APC group than
in the placebo group were discharged directly home.
Not happy with follow up to hospital discharge, Angus and
coworkers [9] collected long-term survival data up to18
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3.5 years after PROWESS. They aimed to determine the
effect of APC on hospital survival (as described above) and
then to investigate the ensuing long-term survival and to
analyze these results for selected subgroups based on age,
premorbid functional dependency, Acute Physiology and
Chronic Health Evaluation (APACHE) II score and number of
organ dysfunctions, all of which are known to have
prognostic significance in severe sepsis. Sadly, despite
survival to hospital discharge being better in those treated
with APC, rates of overall median survival and survival at
3 months, 6 months, 1 year and 2.5 years were not
significantly different between the APC and placebo groups.
This finding was consistent for subgroup analyses other than
for APACHE II scores. In post hoc analysis, patients with an
initial APACHE II score in excess of 25 had a survival benefit
when treated with APC. This persisted to 30 months.
Both groups of authors emphasized the significant limitations
to these types of studies. Retrospective, cross-sectional
observations, use of post hoc analysis and small sample
sizes that are not powered for the analysis in question must
temper over interpretation. However, it is unlikely that a new
long-term prospective trial studying the effect of APC in
severe sepsis is now possible, and we must therefore tailor
our clinical practice with these findings in mind.
Noninvasive positive pressure ventilation
In the past few months the journals, as has become the norm,
have been peppered with studies investigating noninvasive
ventilation (NIV) in the management of acute respiratory
failure (ARF) of varying aetiology.
The immunocompromised patient presenting with ARF has
been thought to carry a very poor prognosis, and as such
intensive care physicians have been reluctant to institute
invasive respiratory support. However, recent studies have
demonstrated the efficacy of NIV in this patient population,
providing us with an alternative to endotracheal intubation
[11,12]. Carrying this concept forward, Rocco and
colleagues [13] reported a case–control study comparing
NIV delivered via traditional face mask versus the much
discussed helmet interface for immunocompromised patients
with hypoxaemic ARF and fever. Accepting that numbers in
this study were small and that patients in the helmet group
were matched with historical control individuals receiving
facemask NIV, both groups demonstrated a similar
improvement in PaO2/FiO2 ratio, but importantly the helmet
group demonstrated a more sustained improvement. This
was probably due to a lower incidence of complications,
leading to patient intolerance of the device. A trend toward
reduced mortality in the helmet group was also shown.
An equally unappetizing prospect is the combination of ARF
and haematological malignancy. A further study appearing in
Chest [14] compared NIV with invasive intubation and
ventilation for this patient group. This was a retrospective study
using a pair-wise matching system to compare the two
treatment modalities and logistic regression analysis to identify
factors affecting in hospital mortality. Conclusions need to be
drawn carefully because the study population was quite
heterogeneous with varying types of malignancy and differing
aetiologies to the respiratory failure. In addition, the technique
of NIV changed significantly during the study period. Despite
this the authors identified increasing severity of illness and a
diagnosis of acute myeloid leukaemia as markers of poor
outcome, whereas being female, intubated in the first 24 hours
and the presence of recent positive blood cultures were
markers of good outcome. Make of this what you will.
To end, we return to Critical Care Medicine, December
issue. A prospective randomized trial [15] suggested that
continuous positive airway pressure (CPAP) and/or bilevel
positive airway pressure (BIPAP) is superior to oxygen
therapy alone in acute cardiogenic pulmonary oedema.
Specifically, CPAP and BIPAP resulted in much improved
PaO2/FiO2 ratios and a lower incidence of endotracheal
intubation. No increased incidence of myocardial infarction
was demonstrated in the CPAP/BIPAP groups. However,
there was no significant difference in mortality at hospital
discharge between the groups.
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